Health economics Books

Book SynopsisThis textbook on Healthcare Management provides a systematic and comprehensive overview of the organisational forms and management instruments implemented in managed care.Within the international discussion on the structure of healthcare systems, managed care is an increasingly important topic. Over more than twenty years managed care approaches have fundamentally influenced healthcare systems in terms of patient orientation, efficiency, and quality. Experts assume that up to 20% of healthcare expenses can be saved by applying high-quality managed care approaches. By using suitable organisational forms and management principles, not only can costs be reduced, but the quality of medical service provision can be augmented. Managed care is therefore much more than a cost-cutting strategy. Advocates consider managed care to be a logical and necessary developmental step in modern healthcare systems. An increase in quality and at the same time a reduction of costs is not seen as contradictory but rather as consistent. Therefore, managed care is a response to changed challenges in the provision of healthcare.​Table of ContentsPart I: Basic Ideas of Managed Care.- Definitions and Concepts.- Main Characteristics of the American Healthcare System.- Theoretical Concepts for the Assessment of Managed Care.- Part II: Managed Care Organisations and Products.- Preliminary Remarks.- Insurance-Based Managed Care Organisations and Products.- Provider-Based Managed Care Organisations and Products.- Institutions in the Managed Care Environment.- Conclusion.- Part III: Managed Care Instruments.- Contract Design.- Compensation Systems.- Quality Management.- Cost Management.- Evaluation Procedure.- Part IV: Evaluation of Managed Care.- Preliminary Remarks.- Cost Effects of Managed Care.- Quality Effects of Managed Care.- Access Effects of Managed Care.- Acceptance of Managed Care.- Conclusion.- Index.

Read more less

Book SynopsisChapter 1 Healthcare Systems of the World.- Chapter 2 Future of Health Care Delivery.- Chapter 3 Epidemiological Perspective of HC Management.- Chapter 4 Health Policy & Planning.- Chapter 5 Health Care Finance.- Chapter 6 Evaluating Health Systems.- Chapter 7 Health Care Needs Assessment .- Chapter 8 Approaches to HC Needs Assessment.- Chapter 9 Public Private Partnership.- Chapter 10 Evidence-Based Medicine & Health Care.- Chapter 11 Complimentary & Alternative Health Care.- Chapter 12  Modern Techniques in Hospital Management.- Chapter 13  Administrative Functions.- Chapter 14 Strategic Planning.- Chapter 15 Procurement Management.- Chapter 16 Hospital Information System.- Chapter 17 Medical Records.- Chapter 18 Computerised Medical Records.- Chapter 19  Nursing Services .- Chapter 20 Health Care Marketing.- Chapter 21  Operations Research.- Chapter 22  Transactional Analysis.- Chapter 23  Managing Conflict Among Groups.- Chapter 24 Surgical Audit.- Chapter 25 Total Quality Management.- Chapter 26 Professional Regulation, Law & Ethics.- Chapter 27 Healthcare Technology Assessment.- Chapter 28 Scientific Research.- Chapter 29 Research & Development.- Chapter 30 Health Statistics 31 Medical Ethics.- Chapter 32 Health Services Accreditation.- Chapter 33 Towards Establishing World-Class Universities.- Chapter 34 Organ Transplant.

Read more less

Book SynopsisHealth Econometrics Using Stata by Partha Deb, Edward C. Norton, and Willard G. Manning provides an excellent overview of the methods used to analyze data on healthcare expenditure and use. Aimed at researchers, graduate students, and practitioners, this book introduces readers to widely used methods, shows them how to perform these methods in Stata, and illustrates how to interpret the results. Each method is discussed in the context of an example using an extract from the Medical Expenditure Panel Survey.After the overview chapters, the book provides excellent introductions to a series of topics aimed specifically at those analyzing healthcare expenditure and use data. The basic topics of linear regression, the generalized linear model, and log and Box-Cox models are covered with a tight focus on the problems presented by these data. Using this foundation, the authors cover the more advanced topics of models for continuous outcome with mass points, count models, and models for heterogeneous effects. Finally, they discuss endogeneity and how to address inference questions using data from complex surveys.The authors use their formidable experience to guide readers toward useful methods and away from less recommended ones. Their discussion of "health econometric myths" and the chapter presenting a framework for approaching health econometric estimation problems are especially useful for this aspect.Table of ContentsIntroduction Framework MEPS data The linear regression model: Specification and checks Generalized linear models Log and Box–Cox models Models for continuous outcomes with mass at zero Count models Models for heterogeneous effects Endogeneity Design effects

Read more less

Book SynopsisDie Beiträge in diesem Fachbuch stellen die volkswirtschaftliche Bedeutung des Gesundheitswesens für eine Gesellschaft aus unterschiedlichen Blickwinkeln dar. Dabei werden wirtschaftliche, sozialwissenschaftliche, medizinische und rechtliche Perspektiven eröffnet. Nach einem Überblick über die Komplexität und einer Einordnung der Vielfalt des Gesundheitswesens folgen Einblicke in die Sichtweisen der jeweiligen Stakeholder im Gesundheitssystem. Aber auch auf aktuelle methodische, prozessuale und technologische Fragestellungen und Herausforderungen wie z.B. digitale Gesundheitstechnologien wird, teils aus theoretischer und teils aus Praxissicht, eingegangen. Diese Interdisziplinarität ermöglicht es dem Leser, den eigenen Fokus zu erweitern und eine ganzheitlichere und zugleich diversifiziertere Sicht auf ein zentrales Funktionalsystem moderner Gesellschaften zu fördern. Neben der wenig überraschenden Bestätigung, dass das Gesundheitswesen eine signifikante wirtschaftliche Bedeutung für eine Volkswirtschaft hat, zeigen die Einzelbeiträge auch dessen Komplexität und Vielschichtigkeit sowie die Notwendigkeit immer wieder neu auszuhandelnder Kompromisse teils widerstreitender Interessen und Zielsetzungen.Table of ContentsAusgewählte Aspekte des Gesundheitswesens aus volkswirtschaftlicher Sicht.- Institutionelle ambulante ärztliche Versorgung.- Die ökonomische Dimension von Betrug und Missbrauch in der gesetzlichen Krankenversicherung und die Bedeutung des „verhinderten Schadens“.- Mehr Kooperation wagen!.- Digitale Gesundheitstechnologien in der gesetzlichen Kranken- und Pflegeversicherung. Evidenz und Preisfindung aus rechtlicher und ökonomischer Perspektive.- Vom Symptom über die Lebensqualität zur Funktionalität und Teilhabe.- IMPAKT© als Treiber effizienter Behandlung chronischer Krankheiten.- Die Entwicklung des deutschen Gesundheitssystems bei einer linearen Fortschreibung seiner demografischen Beeinflussungsdeterminanten.- Quantifizierung des Gesundheitszustandes im Hinblick auf makroökonomische Analysen.

Read more less

Book Synopsis

Read more less

Book SynopsisFrom a leading political thinker, this book is both an invaluable playbook for meeting our current moment and a stirring reflection on the future of democracy itself.Trade Review"Political theorist Allen shrewdly analyzes how and why the US response to COVID-19 fell short, and suggests what should be done to better prepare for the next pandemic. . . . This is a trenchant call for reimagining how America functions in a time of crisis." * Publishers Weekly *"In this stirring manifesto, the renowned political theorist Allen argues that the United States’ woeful response to the COVID-19 pandemic must serve as a wake-up call for Americans to rebuild their public health infrastructure and renew their constitutional democracy." * Foreign Affairs *"In her new book, Democracy in the Time of Coronavirus, Allen argues that federalism, rather than being a problem, offers solutions to what ails democracy today. In particular, she embraces what she calls 'cooperative federalism.' . . . For Allen, cooperative federalism suggests that the federal government should focus on the big picture: setting overarching goals and identifying promising practices for how best to respond to the pandemic. In contrast, states, counties, cities, and local governments should concentrate on 'the nitty-gritty'—contact tracing, testing, treating the ill, and supporting those who are isolating." * Nation *"It’s not the first political book on the pandemic, but it’s the first I’ve taken seriously so far. . . . It takes a truly original thinker to excite the intellectual public with fresh insights on the pandemic. Allen is the political thinker the modern intelligentsia has patiently held their breath to learn from. She is among the foremost theorists on democracy so an opportunity to uncover her thoughts on how the pandemic exposed cracks in modern democratic governance is thrilling. Of course, her purpose is not to tear down democracy, but rather to discover how to repair it for the future." * Democracy Paradox *"[Allen] argues that democracies can learn from health, economic, and political crises how to reestablish social contracts and build pandemic resilience. . . This book concisely identifies the many and multivalent concerns before COVID vaccines became available—a critical period to document—and it also raises a number of provocative arguments that might form the basis for a lively reader discussion. Finally, other scholars and reformers should further consider Allen's views on social rights and integrative policy judgment." * Choice *"[Allen's] book—published during her campaign for Massachusetts governor—has an aspirational quality; it is rich with discussion of the purposes of our federal constitutional democracy, the social contract, and political legitimacy. She focuses exclusively on COVID-19 but uses the crisis to illustrate the larger problems of U.S. governance." * Boston Review *“Allen’s public life has been spent arguing for democracy, living it, teaching it. She is an exemplar of a democratic citizen, putting forth her ideas in public space for open debate and thereby encouraging us all to join her in communal democratic life.” -- Jonathan Lear, Committee on Social Thought, University of Chicago“Allen’s clear understanding of the social and political challenges to an advanced, industrial democracy that lacks foundational trust make this book an important tool in approaching the ongoing COVID-19 pandemic. It is an excellent broad-brush approach to the need for restoring our social contract.” -- Daniel P. Aldrich, author of "Building Resilience: Social Capital in Post-Disaster Recovery"“Scrutinizing our founding document, Allen sees it as a clarion call for equality.” * New York Times Book Review, Editors’ Choice, on "Our Declaration" *“Remarkable. . . . A tour de force.” * New York Review of Books, on "Our Declaration" *“A primer on all that we have been missing. . . . Invaluable.” * Washington Post, on "Our Declaration" *"Political philosopher Danielle S. Allen, Conant University Professor and, for a time, a candidate for the Democratic nomination for governor of Massachusetts, has examined the pandemic in light of America’s social and political arrangements. In Democracy in the Time of Coronavirus, Allen . . . finds deep reasons for concern." * Harvard Magazine *Table of ContentsPreface Chapter 1: Democracy in Crisis Chapter 2: Pandemic Resilience Chapter 3: Federalism Is an Asset Chapter 4: A Transformed Peace: An Agenda for Healing Our Social Contract Acknowledgments References Index

Read more less

Book SynopsisAdvocates a conversation around the genetic risk for breast and ovarian cancers that focuses less on choice and more on care. Offers a new set of conceptual starting points for understanding what is at stake with a BRCA diagnosis and what the focus on choice obstructs from view. Trade Review“This book is groundbreaking, not only for scholars interested in women’s health, or health or science studies more generally, but also for rhetorical scholars and (post)humanists.”—Celeste M. Condit,author of Angry Public Rhetorics: Global Relations and Emotion in the Wake of 9/11“Being at Genetic Risk delves deeply into Mol’s concept of ‘logic of care’; set in the context of the risk of a genetic disease (rather than focusing on patients living with a disease or a difficult-to-define symptom), this adds in significant and interesting ways to the conversation.”—Jodie Nicotra,University of Idaho“Kelly Pender’s Being at Genetic Risk: Toward a Rhetoric of Care makes an important contribution to scholarship in the rhetoric of health and medicine (RHM); rhetoric of science, technology, and medicine (RSTM); and rhetoric more broadly. The book does so by taking on the important task of questioning critiques ‘debunking’ social creations that dupe naïve people into believing their reality.”—Cathryn Molloy Rhetoric Review

Read more less

Book SynopsisAnalyzing the contemporary revolution in the purchasing of health care technology, this book focuses on the roles of the Food and Drug Administration (FDA), Medicare and private health insurers, physicians and hospitals, and consumers themselves.

Read more less

Book SynopsisGuaranteeing that all are insured does not create a system with the quality of care patients want, the flexibility clinicians need, and the internal dynamics for continual improvement of health care value. Luft presents a comprehensive new proposal, SecureChoice, which does all that while providing affordable health insurance for every American.Trade ReviewHal Luft's book deserves and will surely command a wide audience. Concerned public officials as well as concerned citizens will want to consider his comprehensive and detailed approach to ensuring access to quality medical care while controlling costs. -- Rashi Fein, coauthor of The Health Care Mess: How We Got into It and What It Will Take to Get OutThis book has some marvelous and novel ideas about how to restructure our health care system. -- Ezekiel J. Emanuel, author of Healthcare, Guaranteed: A Simple, Secure Solution for AmericaAn innovative, stimulating, well-written prescription for health care reform. -- Victor R. Fuchs, author of Who Shall Live? Health, Economics, and Social ChoiceIn America, we pay more than any other country does for health care that has inconsistent quality, leaves millions uninsured, and wastes billions of dollars on unnecessary care and administration. In Total Cure, Hal Luft recognizes that changing the payment system must be the foundation for any real health reform. -- Peter V. Lee, Executive Director, National Health Policy, Pacific Business Group on HealthLuft has written a sober, thoughtful volume...It may also prove very influential. -- David Gratzer * Forbes *Economist Harold Luft presents a thought-provoking and original proposal in Total Cure...Now is the time to evaluate SecureChoice and other health care proposals. Swift action is crucial if policymakers are to take advantage of this defining moment to enact health care reforms. -- Marian E. Gornick * New England Journal of Medicine *Of the numerous discussions of health care reform, many are longer on diagnosis than on prescription. Total Cure: The Antidote to the Health Care Crisis is a notable exception to that tendency. After presenting a brief overview of the state of U.S. health care, it turns quickly to developing an innovative reform proposal, and it does so in considerably greater depth than most similar books...SecureChoice is an ingenious, carefully constructed proposal...Some readers not versed in health policy may find Total Cure: The Antidote to the Health Care Crisis challenging. It rewards the effort, however, by providing both an important new health care reform option and an illuminating tutorial on the issues at stake. -- Samuel Y. Sessions * Journal of the American Medical Association *Total Cure in whole or in part should definitely be included in the syllabus of a course that addresses what we might do to reform the U.S. health care system. And for those who want to be challenged to think about how they would restructure our health care system, Total Cure is a great read--it makes you think hard. -- Katherine Swartz * Inquiry *Are you sitting down? I have in hand a 318-page health care reform plan that could actually work. Really. Harold Luft's Total Cure is a calm, fearless leap across the abyss of health policy cynicism and the greatest of improbabilities: a comprehensive, detailed, and practical CTRL-ALT-DEL for the U.S. health care system...Luft's Total Cure is just what the policy doctors on Capitol Hill will need: a wise, postpartisan, durable shop manual for how to make health reform actually happen in our time. -- J. D. Kleinke * Health Affairs *Brilliant and badly underappreciated...Luft seems to recognize that advances in medical technology make the traditional approach to private health insurance less viable. Yet he also sees the value in promoting constructive competition. Part of the appeal of Luft's approach is that it is very open-ended: While [Universal Coverage Pool] coverage for big-ticket costs is mandatory, wraparound coverage is optional. His plan could be financed through something like our current system of tax incentives for employers, or we could finance it through taxes. And though fairly complex in its details, the basic outlines are simple and attractive: With the UCP in place, no one will ever go bankrupt due to illness; private insurers and providers will compete on the basic of cost and quality; and the health system will get better and cheaper over time. -- Reihan Salam * Forbes.com *Table of Contents* Preface * List of Tables and Figures * List of Abbreviations * Introduction * Build on What You've Got, but Recognize Real-World Constraints * Overview of a Restructured Health Care System * Covering the Cost of Care: Rethinking Health Insurance * Organizing Care and Paying Providers * Choices: Harnessing Data to Inform Decisions * Financing SecureChoice * Malpractice, Pharmaceuticals, Medical Education, and Prevention * How SecureChoice Would Work for Patients and Physicians * Getting There: Policy Choices, Implementation, and Transition * Notes * Glossary * Index

Read more less

Book SynopsisFrom Nobel Prizewinning economist Michael Kremer and fellow leading development economist Rachel Glennerster, an innovative solution for providing vaccines in poor countriesMillions of people in the third world die from diseases that are rare in the first worlddiseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world''s poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: Pull programs to stimulate research. Here''s how such programs would work. Funding agencies would commit toTrade ReviewWinner of the 2004 Award for Best Professional/Scholarly Book in Medical Science, Association of American Publishers "This book should interest anyone involved in international public health, politics and economics. It is a valuable effort to find a practical solution to a major problem."--Pierre Chirac, NatureTable of ContentsForeword ix Acknowledgments xiii 1.INTRODUCTION 1 2.HEALTH IN LOW-INCOME COUNTRIES 6 The Disease Environment in Low-Income Countries 6 Weak Health-Care Infrastructure 7 Malaria, Tuberculosis, and HIV/AIDS 11 The Impact of Cheap, Simple Technologies 20 3.THE PAUCITY OF PRIVATE R&D TARGETED TO THE NEEDS OF LOW-INCOME COUNTRIES 25 The Extent of R&D Targeted to Low-Income Countries 25 The Scientific Potential for New Vaccines 27 4.MARKET AND GOVERNMENT FAILURES 29 Why Target Foreign Assistance to Vaccine R&D? 30 The Patent Tradeoff 33 Low-Income Countries and Intellectual Property 36 Social versus Private Return: Some Quantitative Estimates 40 The Role of Public Purchases 42 5.THE ROLE OF PUSH PROGRAMS 45 Meningococcal Meningitis: An Example of a Successful Push Program 46 A Cautionary Tale: The USAID Malaria Vaccine Program 47 Incentives under Push Programs 49 6.THE POTENTIAL ROLE OF PULL PROGRAMS 55 The Effect of Market Size on Innovation 55 The Impact of Financial Incentive Programs 56 Examples of Pull Programs Stimulating Research 59 Advantages and Limitations of Pull Programs 63 7.PULL PROGRAMS: A MENU 68 Commitments to Finance Purchase of Products and Patents 68 Patent Extensions on Other Pharmaceuticals as Compensation for Vaccine Development 70 Best-Entry Tournaments 72 Expanding the Market for Existing Vaccines and Drugs 73 8.DETERMINING ELIGIBILITY 76 Basic Technical Requirements 76 Independent Adjudication Committee 78 Market-Test Requirement 81 Exit Clauses 84 9.HOW MUCH SHOULD WE PROMISE TO PAY FOR A VACCINE? 86 What Market Size Is Needed to Spur Research? 86 Cost-Effectiveness: What Is a Vaccine Worth? 90 10.HOW SHOULD PAYMENT BE STRUCTURED? 97 Paying for Multiple Vaccines and Market Exclusivity 100 Bonus Payments Based on Product Quality 103 Increasing the Promised Price over Time 105 Avoiding Windfalls 106 Industry Consultations 107 11.SCOPE OF THE COMMITMENT 109 What Diseases to Cover? 109 Vaccines, Drugs, and Other Technologies 109 Incentives for Agricultural R&D 112 12.MOVING FORWARD WITH VACCINE COMMITMENTS 115 Making a Commitment Legally Binding 116 The Politics of Creating Markets for Vaccines and Drugs 118 Potential Sponsors of New Markets for Vaccines and Drugs 119 References 127 Index 145

Read more less

Book SynopsisFor the past few years, the author, a renowned economist, has been applying the statistical tools of economics to decision making under uncertainty in the context of patient health status and response to treatment. He shows how statistical imprecision and identification problems affect empirical research in the patient-care sphere.Trade Review"Medicine has made spectacular advances, but its techniques for approving and selecting treatments remain locked in statistical and experimental design methods developed in the first decades of the twentieth century. In this book, Manski gives an accessible, practical explanation for why failures to confront the ambiguities of treatment decisions harm patients. He describes how modern statistical decision theory, including his own contributions, can save lives if incorporated into medical training and the decision making of clinicians, standard-setting bodies, and regulatory agencies. This is a must-read for those who take the Hippocratic Oath seriously."—Daniel McFadden, Nobel Laureate in Economics "Manski proposes clear, powerful strategies for improving patient care amid the many uncertainties typifying healthcare-delivery environments. Patient Care under Uncertainty offers valuable insights that wise clinicians—and others working in healthcare systems or on health policy design—would do well to consider and to implement in practice."—John Mullahy, University of Wisconsin–Madison “A thoughtful critique of medical decision making, Patient Care under Uncertainty furthers clinical care and evidence-based medicine. Manski examines identification practices, introduces partial identification to a clinical audience, and builds our econometric/statistical toolkit. Just as social scientists have adopted randomized clinical trials, it would be worthwhile for clinicians to adopt Manski’s rich approach to econometrics.”—Ahmad von Schlegell, MD"In this book, Manski highlights the tension between evidence generation in medicine and its credible use in healthcare decisions. Relying on decades of research, he presents various decision-theoretic principles for making better choices in the face of uncertainty. Accessible to a wide range of audiences, this book is a must-read for anyone grappling with the place of evidence in medical choices."—Anirban Basu, University of Washington

Read more less

Book SynopsisA transformative approach to public health and social care in the wake of Covid-19Trade Review‘A brilliant exposé of how the political left in Britain is unaware of, and can start to begin to address, the effects of ever-increasing opting-out from public health and care services by those who can’ -- Danny Dorling, Professor of Geography at the University of Oxford'The boldest blueprint for public health since Bevan' -- Sonia Adesara, NHS Doctor and Campaigner'The ideas in this book are as significant and radical as the birth of the NHS, it shows a new, fairer vision for improving the health of the nation and a comprehensive plan for how to do it' -- Shirley Cramer, former CEO of the Royal Society for Public Health'A vital book that shows just how broken the health status quo truly is. Thomas' work will arm campaigners to demand a better, more just public health system - and to defend human life against corporate exploitation' -- Dr Aseem Malhotra, author of 'A Statin-Free Life' and Founder of Public Health Collaboration'A well-argued plan to bring together health, social and economic justice' -- Andy McDonald MP'A fantastically well written book that shows just how much public health has been neglected in the UK and the actions we need now' -- Dr Jyotsna Vohra, Director of Policy and Public Affairs at the Royal Society for Public HealthTable of ContentsAbbreviations List of Tables Acknowledgements Preface Introduction 1. The NHS Frontier 2. The Social Justice Frontier 3. The Economic Frontier 4. The Social Care Frontier 5. The Sustainability Frontier 6. The Public Health New Deal Epilogue: Labour’s Medicine Notes Index

Read more less

Book SynopsisIn 2008, the University of Pittsburgh Medical Centers (UPMC) hoisted its logo atop the U.S. Steel Building in downtown Pittsburgh, symbolically declaring that the era of big steel had been replaced by the era of big medicine for this once industrial city. More than 1,200 miles to the south, a similar sense of optimism pervaded the public discourse around the relationship between health care and the future of Houston''s economy. While traditional Texas industries like oil and natural gas still played a critical role, the presence of the massive Texas Medical Center, billed as the largest medical complex in the world, had helped to rebrand the city as a site for biomedical innovation and ensured its stability during the financial crisis of the mid-2000s.Taking Pittsburgh and Houston as case studies, The Medical Metropolis offers the first comparative, historical account of how big medicine transformed American cities in the postindustrial era. Andrew T. Simpson explores hTrade Review"Simpson demonstrates the impressive depth and breadth of his research. He not only chronicles the major developments in the health care industry in each city, he also peels back the curtain on the internal deliberations of the major players as they made strategic decisions. These details provide useful insights for those interested in nonprofit governance and public-private partnerships, particularly in the context of urban economic development. Likewise, these case studies chronicle how national trends in American health care throughout the 20th century affected local health care industries." * Journal of Urban Affairs *"Access to health care remains near the center of American political discourse. Based on two local studies, Andrew T. Simpson deftly explains the economic imperatives of postwar urban sprawl in molding the shifting relationship between medical centers and the communities they serve." * Guenter B. Risse, author of Mending Bodies, Saving Souls: A History of Hospitals *"Well framed and full of insights for audiences in urban history, business history, health policy, and the history of medicine, this book interleaves the soaring visions and sobering realities of two American cities that sought to promote hopeful social and economic futures by investing in not-for profit health institutions. By situating the uncontrolled growth of U.S. healthcare expenditures alongside deliberate local and regional plans to realize civic improvement through healthcare revenues, Andrew T. Simpson firmly establishes the role of place, contingency, and governance in shaping the seemingly ungovernable system that threatens to bankrupt municipal economies at the same time that it promises to save them." * Jeremy Greene, author of Generic: The Unbranding of Modern Medicine *Table of ContentsIntroduction. Making the Medical Metropolis Chapter 1. Building Cities of Health: Medical Centers in Pittsburgh and Houston Before 1965 Chapter 2. The Hospital-Civic Relationship in the Shadow of the Great Society Chapter 3. City of Hearts, City of Livers: Specialty Medicine and the Creation of New Civic Identities Chapter 4. "When the Fire Dies": Biotechnology and the Quest for a New Economy Chapter 5. The Coming of the System: Changing Health Care Delivery in the Medical Metropolis Chapter 6. A Charitable Mission or a Profitable Charity? Redefining the Hospital-Civic Relationship Epilogue. The Future of the Medical Metropolis Notes Archival Collections and Abbreviations Index Acknowledgments

Read more less

Book SynopsisIncluding an array of distinguished contributors, this novel book fills a gap in the literature by addressing an important yet under researched issue in the field of sports economics.Trade Review‘The reading of the book is stimulating and equally informative; engaging in sport activities appear to really matter for overall labour productivity market outcomes and the readers are told, individual life satisfaction is reportedly three times higher when participating in physical activity than happiness associated with employment. . . highly innovative and insightful, having the merit of filling a gap in the literature of the, yet under-researched, field of sports economics.’ -- Constantin Oprean, Management of Sustainable DevelopmentTable of ContentsContents: Introduction Plácido Rodríguez, Stefan Késenne and Brad R. Humphreys 1. Participation in Physical Activity and Health Outcomes: Evidence from the Canadian Community Health Survey Jane E. Ruseski and Brad R. Humphreys 2. An Economic Analysis of the Subjective Health and Well-being of Physical Activity Paul Downward and Simona Rasciute 3. Physical Activity and Obesity in Spain: Evidence from the Spanish National Health Survey Jaume García Villar, Sonia Oreffice and Climent Quintana-Domeque 4. Does Physical Exercise Affect Demand for Hospital Services? Evidence from Canadian Panel Data Nazmi Sari 5. Leisure Sports Participation in Switzerland Michael Lechner 6. Do Sporty People Have Access to Higher Job Quality? Charlotte Cabane 7. Team Success, Productivity and Economic Impact Michael C. Davis and Christian M. End 8. Sports Participation and Happiness: Evidence from US Micro Data Haifang Huang and Brad R. Humphreys 9. Subjective Well-being and Engagement in Sport: Evidence from England David Forrest and Ian G. McHale 10. High School Sports and Teenage Births Joseph Price and Daniel H. Simon 11. Physical Activity and Subjective Well-being: An Empirical Analysis Georgios Kavetsos 12. Sport Opportunities and Local Well-being: Is Sport a Local Amenity? Tim Pawlowski, Christoph Breuer and Jorge Leyva Index

Read more less

Book SynopsisA key risk factor for a range of chronic diseases, obesity has become a major public health concern. It argues that efforts to prevent obesity and related chronic diseases can provide the means to increase social welfare and enhance health equity, relative to a situation in which chronic diseases are simply treated once they emerge.Trade Review‘This volume, initiated by the OECD, provides an overview of trends and future projections of obesity; discusses the economic costs associated with this major health issue; and examines various government and market strategies designed to prevent this growing problem. . . A timely, valuable volume on a critical issue. . . Highly recommended.’ -- E.P. Hoffman, Choice‘This book presents a valuable set of results and suggestions about the best preventive interventions to reduce the burden of obesity. It will aid any country concerned about this burden in defining public policies aimed at altering current trends.’ -- Julio Frenk, Harvard School of Public Health, US‘The positive message of this book is that the obesity epidemic can be successfully addressed by comprehensive strategies involving multiple interventions directed at individuals and populations.’ -- Ala Alwan, World Health Organization‘This innovative and well-researched book combines insights from a wide range of disciplines. It provides a clear exposition of the evidence that policy makers need to take action.’ -- Martin McKee, London School of Hygiene and Tropical Medicine, UKTable of ContentsContents: 1. Introduction: Obesity and the Economics of Prevention Special Focus I: Promoting Health and Fighting Chronic Diseases: What Impact on the Economy? by Marc Suhrcke 2. Obesity: Past and Projected Future Trends 3. The Social Dimensions of Obesity Special Focus II: The Size and Risks of the International Epidemic of Child Obesity by Tim Lobstein 4. How Does Obesity Spread? Special Focus II: Are Health Behaviors Driven by Information? by Donald Kenkel 5. Tackling Special Focus IV: Community Interventions for the Prevention of Obesity by Francesco Branca 6. The Impact of Inventions Special Focus V: Regulation of Food Advertising to Children: The UK Experience by Jonathan Porter Special Focus VI: The Case of Self-Regulation in Food Advertising by Stephan Loerke 7. Information, Incentives and Choice: A Viable Approach to Preventing Obesity Annexes

Read more less

Book SynopsisInnovation and Health investigates both the origin and the diffusion of novelty in the field of health.Trade ReviewIn this thought provoking and insightful book, Thomas Grebel provides the contours of a novel theoretical framework allowing us to cope with the complex nature of the creation, diffusion and normative direction of innovations in the health sector. Multi-disciplinary in scope and rigorous in technical and appreciative analysis, this book makes a major contribution to our understanding of the evolution of knowledge in general and the dynamic and complex nature of medical innovations in particular. Anyone seriously interested in theoretical and normative groundwork for an evolutionary knowledge-based approach to health economics will have to stop and listen. --Kurt Dopfer, University of St Gallen, SwitzerlandTable of ContentsContents: Preface 1. Introduction 2. Change in Economics 3. Health Economics 4. Towards a Theory of Innovation in Health Economics 5. Knowledge Creation in Medicine 6. Network Evolution in Medicine 7. Technology Diffusion in Medicine 8. Conclusion Bibliography Index

Read more less

Book SynopsisHIV/AIDS is much too complex a phenomenon to be understood only by reference to common sense and ethical codes. This book presents the costâbenefit analysis (CBA) framework in a well-researched and accessible manner to ensure that the most important considerations are recognized and incorporated.Trade Review‘Professor Brent’s book is a superlative addition to the HIV/AIDS policy literature. Both non-specialists and specialists in policy evaluation will benefit from the lucid exposition of cost–benefit analysis (CBA) methods applied to the most critical and far-reaching problem that challenges social institutions and individual behavior. Essentially, Professor Brent has taken his vast experience in cost–benefit analysis, and on the ground African research, to apply CBA in a compelling and insightful manner. This book re-examines HIV/AIDS policy in Sub-Saharan countries where the devastation is an infection tsunami. . . Finding what actually works may be difficult, but Professor Brent argues persuasively that using a CBA framework is the best approach.’ -- William S. Cartwright, George Mason University, USTable of ContentsContents: Preface PART I: WHY COST–BENEFIT ANALYSIS IS NEEDED TO SET HIV/AIDS PRIORITIES 1. Introduction to the Book 2. Why Not Just Simply do What is Right and Try to Save Lives? 3. Myths and Misinformation 4. Counterintuitive Results 5. What is Wrong with Setting any Targets? 6. What is Wrong with Setting the Particular MDG Targets? 7. Cost–Benefit Analysis 101 8. Cost–Benefit Analysis 201 PART II: HIV/AIDS AS A HUNGER AND ECONOMIC DEVELOPMENT ISSUE 9. Introduction to Part II 10. HIV and Hunger 11. Nutrition and HIV at the Individual Level 12. Nutrition and HIV at the Country Level 13. Income as a Factor Raising HIV Rates 14. Education as a Factor Raising HIV Rates 15. Islam as a Factor Lowering HIV Rates 16. Impact of HIV on Agricultural Households 17. Agricultural Policy and HIV Interventions 18. Sex and HIV I: The Role of Transmission 19. Sex and HIV II: The Role of Concurrency 20. Sex and HIV III: The Role of Networks PART III: COST–BENEFIT METHODS AND APPLICATIONS 21. Introduction to Part III 22. Threshold Analysis Theory 23. Threshold Analysis Practice: The Effectiveness of HIV Education 24. Threshold Analysis Practice: The Benefits of Avoiding HIV 25. Threshold Analysis Practice: The Costs of a Possible HIV/AIDS Vaccine 26. Willingness to Pay Theory 27. Willingness to Pay Practice: The Benefits of Condoms 28. Cost Minimization Theory 29. Cost Minimization Practice: The Costs of Treating TB 30. Cost-Effectiveness Theory 31. Cost-Effectiveness Practice: The Benefits of ARVs 32. Human Capital Theory 33. Human Capital Practice: The Benefits of Female Primary Education 34. Value of a Statistical Life Theory 35. Value of a Statistical Life Practice: The Benefits of VCT PART IV: SOCIAL CONSIDERATIONS IN CBA 36. Introduction to IV 37. Commodification: Everything is Seen as a Commodity to be Bought and Sold 38. What is So “Social” About CBA? Fundamentals of CBA 39. Social and Private Perspectives in CBA 40. CBA and Equity I: Allowing for Ability to Pay 41. CBA and Equity II: Allocating by Time and Other Non-Price Methods 42. Conclusions I: How Not to Set Priorities for HIV 43. Conclusions II: Using CBA to Set Priorities for HIV References Index

Read more less

Book SynopsisEach of these issues are broken down further and split into six comprehensive sections:• Context• Pensions• Health• Welfare• Case Studies• Policy Innovation and Civil SocietyAcademics interested in policy challenges for mature societies will find this Handbook a highly relevant reference tool.Trade Review‘International Handbook on Ageing and Public Policy gathers under one cover the collective knowledge of experts in the field who explore challenges arising from ageing populations around the world, and considers national state approaches to welfare for older people and how public and private initiatives work. College-level collections strong in public policies and aging with find this a powerful collection of in-depth articles suitable for framing inquiries and considering social structures.’ -- The Midwest Book Review‘This Handbook on ageing and public policy makes a substantial contribution in bringing together chapters spanning a -- breadth of issues in the areas of policy challenges and practitioner perspectives.’– EE Journal 1848 Social Policy & AdministrationTable of ContentsContents 1. Introduction: Conceptualising Social Policy for the Twenty-first-century Demography Sarah Harper 2. Introduction to Parts I-IV: Perspectives on the Challenges of Population Ageing PART I: POLICY CHALLENGES FOR MATURE SOCIETIES – CONTEXT 3. Drivers of Demographic Change in the Twentieth and Twenty-first Centuries George W. Leeson 4. A Biodemographic Perspective on Longevity and Ageing Bruce A. Carnes 5. Migration and Ageing Societies Sarah Harper 6. On the Mechanical Contributions of Ageing to Global Income Inequality Parfait M. Eloundou-Enyegue and Michael Tenikue 7. Population Ageing and the Size of the Welfare State Vincenzo Galasso and Paola Profeta PART II: POLICY CHALLENGES FOR MATURE SOCIETIES – PENSIONS 8. Global Pension Systems Robert Holzmann 9. The Design and Implementation of Pension Systems in Developing Countries: Issues and Options David E. Bloom and Roddy McKinnon 10. Understanding Pension Wealth Zhenyu Li and Anthony Webb 11. Rational Pension Reform Axel Börsch-Supan 12. National Transfer Accounts and Intergenerational Transfers Ron Lee and Andy Mason PART III: POLICY CHALLENGES FOR MATURE SOCIETIES – HEALTH 13. Assessing the Cost Effectiveness of Therapies for Older People Richard Edlin 14. Population Ageing and Health Care Expenditure Growth Ed Westerhout 15. Developing Appropriate and Effective Care for People with Chronic Disease Bert Vrieheof and Arianne Elissen PART IV: POLICY CHALLENGES FOR MATURE SOCIETIES – WELFARE 16. Sustainability and Intergenerational Justice in Age-related Transfers Kenneth Howse 17. Health and Social Protection Policies for Older People in Latin America Peter Lloyd-Sherlock 18. Ageing Electorates and Gerontocracy: The Politics of Ageing in a Global World Fernando M. Torres-Gil and Kimberly Spencer-Suarez 19. Working Beyond Retirement Age: Lessons for Policy David Lain and Sarah Vickerstaff 20. Families, Older Persons and Care in Contexts of Poverty: the Case of South Africa Jaco Hoffman PART V and VI: PRACTIONER PERSPECTIVES 21. Policy and Practitioner Responses to the Challenges of Population Ageing: Introduction Jaco Hoffman 22. Sustaining the Nordic Welfare Model in the Face of Population Ageing Virpi Timonen and Mikko Kautto 23. Kinship Solidarity in Southern Europe Chiara Saraceno 24. Ageing and Social Policy in Australia Jeni Warburton 25. The Pension System in China: An Overview Taichang Chen 26. How Technology is Re-shaping the Processes of Providing Health Care for Ageing Populations Robin Gauld 27. Ageing and Care Giving in America: the Immigrant Workforce B. Lindsay Lowell 28. Canada’s Live-in Caregiver Programme Ivy Lynn Bourgeault and Jelena Atanackovic PART VI: PRACTIONER PERSPECTIVES – POLICY INNOVATION AND CIVIL SOCIETY 29. Intergenerational Programmes and Policies in Aging Societies Matthew Kaplan and Mariano Sánchez 30. Population Ageing and Private Sector Provision: the Case of Dependent Older Women in Latin America Nélida Redondo 31. Demographic Change and the Role of Older People in the Voluntary Sector Karsten Hank and Marcel Erlinghagen 32. The Third Sector as a Provider of Services for Older People Ewa Leś 33. State-third Sector Partnership Frameworks: from Administration to Participation? Ingo Bode 34. Microfinance, Cooperatives and Timebanks- Community Provided Welfare Ed Collom 35. Faith-Based Organizations and the Provision of Care for Older People Lori Carter-Edwards, James H. Johnson Jr., Allan M. Parnell and Harold G. Koenig 36. Lifelong Learning and Employers: Re-skilling Older Workers John Field and Roy Canning 37. Retirement Planning and Financial Literacy Annamaria Lusardi Index

Read more less

Book SynopsisIn this well-documented book, Alain Enthoven develops the ideas of consumer choice and managed competition of alternative health care financing and delivery systems, as well as describing ways to improve quality and reduce the cost of health care.Table of ContentsContents: Introduction 1. ‘Competition of Alternative Delivery Systems’, in Warren Greenberg (ed.), Competition in the Health Care Sector: Past, Present and Future, 1978, 255–77 2. ‘Consumer-Choice Health Plan: Inflation and Inequality in Health Care Today: Alternatives for Cost Control and an Analysis of Proposals for National Health Insurance’ and ‘Consumer-Choice Health Plan: A National-Health-Insurance Proposal Based on Regulated Competition in the Private Sector’, New England Journal of Medicine, 298 (12 and 13), 1978, 650–58 and 709–20 3. ‘Shattuck Lecture – Cutting Cost Without Cutting the Quality of Care’, New England Journal of Medicine, 298, June 1, 1978, 1229–38 4. ‘Consumer-centered vs. Job-centered Health Insurance’, Harvard Business Review, 57 (1), 1979, 38–49 5. ‘A New Proposal to Reform the Tax Treatment of Health Insurance’, Health Affairs, 3 (1), 1984, 21–39 6. ‘Managed Competition in Health Care and the Unfinished Agenda’, Health Care Financing Review, Annual Supplement, 1986, 105–19 7. ‘Effective Management of Competition in the FEHBP’, Health Affairs, 8 (3), 1989, 33–50 8. ‘What Can Europeans Learn from Americans?’, Health Care Financing Review, Annual Supplement, 1989, 49–63 9. ‘Internal Market Reform of the British National Health Service’, Health Affairs, 10 (3), 1991, 60–70 10. ‘Quality Management in the NHS: The Doctor’s Role – I and II’, BMJ: British Medical Journal, 304 (6821 and 6822), 1992, 235–39 and 304–8 (with D.M. Berwick and J.P. Bunker) 11. ‘The History and Principles of Managed Competition’, Health Affairs, 12 (Supplement 1), 1993, 24–48 12. ‘In Pursuit of an Improving National Health Service’, Health Affairs, 19 (3), 2000, 102–19 13. ‘Modernising the NHS: A Promising Start, but Fundamental Reform is Needed’, BMJ: British Medical Journal, 320, 13 May 2000, 1329–31 14. ‘Employment-Based Health Insurance is Failing: Now What?’, Health Affairs Web Exclusive, http://content.healthaffairs.org/content/early/2003/05/28/hlthaff.w3.237.citation, 28 May 2003, w3-237–49 15. ‘Clinically Integrated Health Care in the English NHS’, Journal of Health Services Research & Policy, 14 (2), 2009, 65–7 16. ‘Going Dutch – Managed-Competition Health Insurance in the Netherlands’, New England Journal of Medicine, 357 (24), 2007, 2421–3 (with Wynand P.M.M. van de Ven) 17. ‘A Living Model of Managed Competition: A Conversation with Dutch Health Minister Ab Klink’, Health Affairs, 27 (3), 2008, w196–203 18. ‘Consumer Choice of Health Plan: Connecting Insurers and Providers in Systems’, Keynote Address for the Dutch/Flemish Association of Health Economists (VGE), Annual Conference at Erasmus University, Rotterdam, November 30, 2006, 1–16 19. ‘Competition in Health Care: It Takes Systems to Pursue Quality and Efficiency’, Health Affairs, Web Exclusive, http://content.healthaffairs.org/content/early/2005/09/07/hlthaff.w5.420.citation, 7 September 2005 w5-420–33 (with Laura A. Tollen) 20. ‘“Redefining Health Care”: Medical Homes or Archipelagos to Navigate?’, Health Affairs, 26 (5), 2007, 1366–72 (with Francis J. Crosson and Stephen M. Shortell) 21. ‘The U.S. Experience with Managed Care and Managed Competition’, in Jane Sneddon Little (ed.), Wanting It All: The Challenge of Reforming the U.S. Health Care System, 2005, 97–117 22. ‘Curing Fragmentation with Integrated Delivery Systems: What They Do, What Has Blocked Them, Why We Need Them, and How to Get There from Here?’, in Einer Elhauge (ed.), The Fragmentation of U.S. Health Care: Causes and Solutions, 2010, 61–85

Read more less

Book SynopsisTrade Review‘If you are looking for an engaging treatment by an economist of what optimal pandemic policy response should look like, and what common pitfalls to avoid, that brings to bear insights from epidemiology, economics, and behavioural economics, then I would highly recommend Nudged into Lockdown. Consider this your nudge.’ -- Jeremy Clark, Journal of Economic Psychology‘Nudged into Lockdown? forcefully addresses an important point that has too often gone missing in applied work on nudging and choice architecture: namely, that policy makers and experts, too, make systematic errors when interpreting data and may succumb to biased assessments of risk and uncertainty themselves. The book provides durable insights into how both orthodox benefit-cost analysis and key findings from the behavioural sciences – regarding trust, autonomy and pro-social adaptative responses in decentralised social systems – were sometimes overlooked or underutilised by those who designed covid-response policies.’ -- Nathan Berg, Journal of Behavioral and Experimental Economics‘In responding to the novel coronavirus pandemic, most governments abandoned the existing scientific and policy consensus and mimicked one another to embrace lockdowns of varying stringency. Remarkably, hardly any seemed to produce cost–benefit analysis. Unremarkably, the cost–benefit balance varied between rich and poor countries. In this rigorous, multi-disciplinary examination, written in clearly accessible language, Ananish Chaudhuri explores the reasons for the herd-like behaviour by governments and for the public compliance with their edicts. A must-read for understanding what really happened with Covid-19 and why, and for being better prepared for the inevitable next pandemic.’ -- Ramesh Thakur, Director of the Centre for Nuclear Non-Proliferation and Disarmament (CNND), Crawford School, The Australian National University, Vice Rector and Senior Vice Rector of the United Nations University and Assistant Secretary-General of the United Nations 1998–2007‘This book is at once scholarly and readily accessible to all. The case Chaudhuri makes is not for any specific policy response, but rather for rational and fully informed decisions – for epidemiology over ideology. If the careful logic and vivid illustrations here pry open enough minds, we will be far better prepared for the next great public health crisis than we were for Covid-19.’ -- David L. Katz, MD, MPH President, True Health Initiative and Founding Director, Yale-Griffin Prevention Research Center, Yale University, US, 1998–2019‘Ananish Chaudhuri lays out the many irrationalities involved in the support for lockdowns in New Zealand and elsewhere: an inability to judge small probabilities, the problems with gut feelings, and many ex-post justification biases. Chaudhuri makes the argument carefully and yet manages to retain great humanism and compassion. A delight to read.’ -- Paul Frijters, Professor in Wellbeing Economics, London School of Economics and Political Science, UK and co-author of An Economic Theory of Greed, Love, Groups, and Networks‘In response to the Covid pandemic, many countries adopted containment policies that did not condition on people’s health status or demographic characteristics. This timely and insightful book addresses the questions of what considerations led to those policies and whether those policies were well-informed. The book begins from the premise that the design of effective policy cannot be based solely on the insights of classic epidemiology models. The reason is both simple and sensible: those models don’t take into account behavioral responses of people to policies like containment. The author’s analysis is multidisciplinary in nature, blending economics, psychology, political science and epidemiology. The result is a rich and informative analysis. I highly recommend this well-written and timely book.’ -- Martin Eichenbaum, Charles Moskos Professor of Economics and Co-Director, Center for International Macroeconomics, Northwestern University, US‘This book is a very timely one for those, like me, who believe the democratic world’s lockdown response to the Covid virus will go down as the worst public policy response of the last few centuries. It is sceptical. It is interesting. It is Great Barrington over Chief Medical Officer. There is more to living and the good life than fear of dying of Covid. All the politicians who focused on that matrix, and ignored other causes of death as well as all the benefits of living in a free society, and more, should have to read this book.’ -- James Allan, Garrick Professor in Law, TC Beirne School of Law, University of Queensland, Australia‘In this book Ananish Chaudhuri achieves the impossible – he offers an easy-to-read book that delivers profound insights about our behavior which applies not just to pandemics, but to many other recurrent situations in our daily lives! A must-read for anyone that wants to make better decisions.’ -- Sudipta Sarangi, Professor and Chair, Department of Economics, Virginia Tech, US, Co-Editor, Journal of Economic Behavior and Organization and author of The Economics of Small Things‘Careful comparison of costs and benefits is usually considered a hallmark of wise decision-making. Yet in 2020 many governments abandoned this standard as they tried to minimize deaths from Covid-19 regardless of cost. Traditional cost–benefit arguments were rebuked, by politicians who by nature rarely admit error, but also by ordinary folk affronted that someone would want to “kill granny”. This book draws insights from experimental economics, political science and psychology to show how various biases in decision-making processes contributed to this situation. Fifty years ago, Essence of Decision led a generation of scholars to examine models of government decision-making. Hopefully Ananish Chaudhuri’s lively book has a similar impact, for scholars, students and members of the public concerned about the retreat from rationality that is revealed by policy choices and public attitudes in the Covid-19 era.’ -- John Gibson, Professor of Economics, University of Waikato, New Zealand, Fellow of the Royal Society of New Zealand and Distinguished Fellow of the New Zealand Association of Economists‘This is an excellent book that nicely discusses cutting-edge applications in behavioural economics pertaining to the Covid-19 pandemic. It is thought-provoking and contains pioneering approaches that broaden the scope of behavioural research. Excellent writing style, making the content of the book accessible to a broad audience. Highly recommended!’ -- Michalis Drouvelis, Professor of Economics, University of Birmingham, UK and Co-ordinating Editor, Theory and Decision‘In New Zealand now it is hard to remember the shock of lockdown as a pandemic response. So much has happened. The virus has been kept at bay, so far. The predicted economic disaster has not happened – yet. Massive financial relief for businesses forcibly suspended and jobs at risk was followed by a rapid recovery when shops reopened. But Ananish Chaudhuri is by no means alone in thinking the country could pay a high and lingering price for its unprecedented lockdown, and that these costs, especially the human costs, should have been weighed against the risks the virus posed. His book uses fascinating behavioral studies of economic decision making and the psychology of popular risk assessment to question the merits of measures that New Zealand’s Government took and New Zealanders overwhelmingly accepted. They should read this book and wonder if these were questions they should have asked.’ -- John Roughan, Political Columnist, New Zealand HeraldTable of ContentsContents: 1. Prologue 2. Gut feelings: biases, heuristics and Covid-19 3. Pathogens and probabilities 4. Should we trust people to do the right thing? 5. Politics, pathogens and party lines 6. Irrational exuberance in the midst of Covid-19 7. Epilogue Bibliography Index

Read more less

Book SynopsisTrade Review‘The book offers a fascinating paradigm to reflect upon dementia interventions, promising to widen the lens of interested governments, public health and policy makers, as well as clinicians alike. By interlinking concepts of protecting human rights, preventing elder abuse, caring for persons living with dementia, all contributing to improving global health and economy, this book offers a solid rationale for an international United Nations convention on the human rights for older persons.’ -- Kiran Rabheru, University of Ottawa, Canada‘Robert Brent’s Cost-Benefit Analysis and Dementia provides a comprehensive and accessible examination of how economic tools can assist in making interventions for dementia more effective. Using state-of-the-art economic methods, Brent examines a broad range of efforts ranging from the role of Medicare eligibility to the importance of vision correction and hearing aids. Despite the rigorous attention to the costs and benefits of alternative policies, the book does not lose sight of concerns such as advocacy of broader protections for the human rights of those with dementia.’ -- W. Kip Viscusi, Vanderbilt Law School, USTable of ContentsContents: Preface PART I INTRODUCTION 1. Introduction to dementia, Cost-Benefit Analysis, and the new interventions 2. Measuring dementia symptoms PART II THE COST-BENEFIT ANALYSES 3. Years of education 4. Medicare eligibility 5. Hearing aids 6. Vision correction 7. Avoiding nursing homes PART III PUBLIC POLICY IMPLICATIONS OF DEMENTIA INTERVENTIONS 8. Elder abuse 9. Human rights Index

Read more less

Book SynopsisHow can analytics scholars and healthcare professionals access the most exciting and important healthcare topics and tools for the 21st century? Editors Tinglong Dai and Sridhar Tayur, aided by a team of internationally acclaimed experts, have curated this timely volume to help newcomers and seasoned researchers alike to rapidly comprehend a diverse set of thrusts and tools in this rapidly growing cross-disciplinary field. The Handbook covers a wide range of macro-, meso- and micro-level thrustssuch as market design, competing interests, global health,personalizedmedicine, residential care and concierge medicine, among othersand structures what has been a highly fragmented research area into a coherent scientific discipline. The handbook also provides an easy-to-comprehend introduction to five essential research toolsMarkov decision process, game theory and information economics, queueing games, econometric methods, and data scienceby illustratTable of ContentsList of Contributors xvii Preface xix Glossary of Terms xxvii Acknowledgments xxxv Part I Thrusts Macro-level Thrusts (MaTs) 1 Organizational Structure 1Jay Levine 1.1 Introduction to the Healthcare Industry 2 1.2 Academic Medical Centers 6 1.3 Community Hospitals and Physicians 16 1.4 Conclusion 19 2 Access to Healthcare 21Donald R. Fischer 2.1 Introduction 21 2.2 Goals 27 2.3 Opportunity for Action 29 3 Market Design 31Itai Ashlagi 3.1 Introduction 31 3.2 Matching Doctors to Residency Programs 31 3.2.1 Early Days 31 3.2.2 A Centralized Market and New Challenges 32 3.2.3 Puzzles and Theory 33 3.3 Kidney Exchange 35 3.3.1 Background 35 3.3.2 Creating a Thick Marketplace for Kidney Exchange 36 3.3.3 Dynamic Matching 38 3.3.4 The Marketplace for Kidney Exchange in the United States 41 3.3.5 Final Comments on Kidney Exchange 43 References 44 Meso-level Thrusts (MeTs) 4 Competing Interests 51Joel Goh 4.1 Introduction 51 4.2 The Literature on Competing Interests 53 4.2.1 Evaluation of Pharmaceutical Products 53 4.2.1.1 Individual Drug Classes 54 4.2.1.2 Multiple Interventions 55 4.2.1.3 Review Articles 56 4.2.2 Physician Ownership 56 4.2.2.1 Physician Ownership of Ancillary Services 57 4.2.2.2 Physician Ownership of Ambulatory Surgery Centers 59 4.2.2.3 Physician Ownership of Speciality Hospitals 60 4.2.2.4 Physician-Owned Distributors 61 4.2.3 Medical Reporting 62 4.2.3.1 DRG Upcoding 63 4.2.3.2 Non-DRG Upcoding 64 4.3 Examples 65 4.3.1 Example 1: Physician Decisions with Competing Interests 66 4.3.2 Example 2: Evidence of HAI Upcoding 70 4.4 Summary and FutureWork 72 References 73 5 Quality of Care 79Hummy Song and Senthil Veeraraghavan 5.1 Frameworks for Measuring Healthcare Quality 79 5.1.1 The Donabedian Model 79 5.1.2 The AHRQ Framework 81 5.2 Understanding Healthcare Quality: Classification of the Existing OR/MS Literature 82 5.2.1 Structure 82 5.2.2 Process 85 5.2.3 Outcome 91 5.2.4 Patient Experience 92 5.2.5 Access 94 5.3 Open Areas for Future Research 95 5.3.1 Understanding Structures and Their Interactions with Processes and Outcomes 95 5.3.2 Understanding Patient Experiences and Their Interactions with Structure 96 5.3.3 Understanding Processes andTheir Interactions with Outcomes 97 5.3.4 Understanding Access to Care 98 5.4 Conclusions 98 Acknowledgments 99 References 99 6 Personalized Medicine 109Turgay Ayer and Qiushi Chen 6.1 Introduction 109 6.2 Sequential Decision Disease Models with Health Information Updates 111 6.2.1 Case Study: POMDP Model for Personalized Breast Cancer Screening 113 6.2.2 Case Study: Kalman Filter for Glaucoma Monitoring 116 6.2.3 Other Relevant Studies 118 6.3 One-Time Decision Disease Models with Risk Stratification 120 6.3.1 Case Study: Subtype-Based Treatment for DLBCL 121 6.3.2 Other Applications 124 6.4 Artificial Intelligence-Based Approaches 125 6.4.1 Learning from Existing Health Data 126 6.4.2 Learning from Trial and Error 127 6.5 Conclusions and Emerging Future Research Directions 128 References 130 7 Global Health 137Karthik V. Natarajan and Jayashankar M. Swaminathan 7.1 Introduction 137 7.2 Funding Allocation in Global Health Settings 139 7.2.1 Funding Allocation for Disease Prevention 139 7.2.2 Funding Allocation for Treatment of Disease Conditions 143 7.2.2.1 Service Settings 143 7.2.2.2 Product Settings 146 7.3 Inventory Allocation in Global Health Settings 147 7.3.1 Inventory Allocation for Disease Prevention 147 7.3.2 Inventory Allocation for Treatment of Disease Conditions 149 7.4 Capacity Allocation in Global Health Settings 153 7.5 Conclusions and Future Directions 155 References 156 8 Healthcare Supply Chain 159Soo-Haeng Cho and Hui Zhao 8.1 Introduction 159 8.2 Literature Review 162 8.3 Model and Analysis 164 8.3.1 Generic Injectable Drug Supply Chain 164 8.3.1.1 Model 166 8.3.1.2 Analysis 168 8.3.2 Influenza Vaccine Supply Chain 171 8.3.2.1 Model 172 8.3.2.2 Analysis 173 8.4 Discussion and Future Research 177 Appendix 180 Acknowledgment 182 References 182 9 Organ Transplantation 187Bar𝚤¸s Ata, John J. Friedewald and A. CemRanda 9.1 Introduction 187 9.2 The Deceased-Donor Organ Allocation system: Stakeholders and Their Objectives 189 9.3 Research Opportunities in the Area 199 9.3.1 Past Research on the Transplant Candidate’s Problem 199 9.3.2 Challenges in Modeling Patient Choice 201 9.3.3 Past Research on the Deceased-donor Organ Allocation Policy 202 9.3.4 Challenges in Modeling the Deceased-donor Organ Allocation Policy 206 9.3.5 Research Problems from the Perspective of Other Stakeholders 206 9.4 Concluding Remarks 208 References 209 Micro-level Thrusts (MiTs) 10 Ambulatory Care 217Nan Liu 10.1 Introduction 217 10.2 How Operations are Managed in Primary Care Practice 218 10.3 What Makes Operations Management Difficult in Ambulatory Care 220 10.3.1 Competing Objectives 220 10.3.2 Environmental Factors 221 10.4 Operations Management Models 222 10.4.1 System-Wide Planning 222 10.4.2 Appointment Template Design 226 10.4.3 Managing Patient Flow 231 10.5 New Trends in Ambulatory Care 234 10.5.1 Online Market 234 10.5.2 Telehealth 235 10.5.3 Retail Approach of Outpatient Care 236 10.6 Conclusion 237 References 237 11 Inpatient Care 243Van-Anh Truong 11.1 Modeling the Inpatient Ward 244 11.2 Inpatient Ward Policies 246 11.3 Interface with ED 247 11.4 Interface with Elective Surgeries 248 11.5 Discharge Planning 250 11.6 Incentive, Behavioral, and Organizational Issues 251 11.7 Future Directions 252 11.7.1 Essential Quantitative Tools 253 11.7.2 Resources for Learners 253 References 253 12 Residential Care 257Nadia Lahrichi, Louis-Martin Rousseau and Willem-Jan van Hoeve 12.1 Overview of Home Care Delivery 257 12.1.1 Home Care 258 12.1.2 Home Healthcare 258 12.1.2.1 Temporary Care 259 12.1.2.2 Specialized Programs 259 12.1.3 Operational Challenges 260 12.1.3.1 Discussion of the Planning Horizon 262 12.1.3.2 Home Care Planning Problem 263 12.2 An Overview of Optimization Technology 263 12.2.1 Linear Programming 263 12.2.2 Mixed Integer Programming 264 12.2.3 Constraint Programming 265 12.2.4 Heuristics and Dedicated Methods 265 12.2.5 Technology Comparison 266 12.2.5.1 Solution Expectations and Solver Capabilities 266 12.2.5.2 Development Time and Maintenance 267 12.3 Territory Districting 267 12.4 Provider-to-Patient Assignment 270 12.4.1 Workload Measures 270 12.4.2 Workload Balance 271 12.4.3 Assignment Models 272 12.4.4 Assignment of New Patients 273 12.5 Task Scheduling and Routing 273 12.6 Perspectives 276 12.6.1 Integrated Decision-Making Under a New Business Model 277 12.6.2 Home Telemetering Forecasting Adverse Events 277 12.6.3 Forecasting the Wound Healing Process 278 12.6.4 Adjustment of Capacity and Demand 279 References 280 13 ConciergeMedicine 287Srinagesh Gavirneni and Vidyadhar G. Kulkarni 13.1 Introduction 287 13.2 Model Setup 291 13.3 Concierge Option—No Abandonment 293 13.3.1 A Given Participation Level 𝛼 294 13.3.2 How to choose d? 295 13.3.2.1 All Customers Are Better Off 295 13.3.2.2 Customers Are Better Off on Average 297 13.3.3 Optimal Participation Level 299 13.4 Concierge Option—Abandonment 301 13.4.1 Choosing the Optimal 𝛼 and 𝛽 303 13.5 Correlated Service Times and Waiting Costs 304 13.6 MDVIP Adoption 306 13.6.1 The Data 307 13.6.2 AbandonmentModel Applied to MDVIP Data 308 13.6.2.1 Modeling Heterogeneous Waiting Costs 309 13.6.2.2 Participation in Concierge Medicine 310 13.6.2.3 Impact of Concierge Medicine 310 13.6.2.4 Choosing the Concierge Participation Level 312 13.7 Research Opportunities 313 References 316 Part II Tools 14 Markov Decision Processes 319Alan Scheller-Wolf 14.1 Introduction 319 14.2 Modeling 321 14.3 Types of Results 325 14.3.1 Numerical Results 325 14.3.2 Analytical Results 327 14.3.3 Insights 328 14.4 Modifications and Extensions of MDPs 328 14.4.1 Imperfect State Information 328 14.4.2 Extremely Large or Continuous State Spaces 329 14.4.3 Uncertainty about Transition Probabilities 330 14.4.4 Constrained Optimization 331 14.5 Future Applications 332 14.6 Recommendations for Additional Reading 333 References 334 15 Game Theory and Information Economics 337Tinglong Dai 15.1 Introduction 337 15.2 Key Concepts 339 15.2.1 GameTheory: Key Concepts 339 15.2.2 Information Economics: Key Concepts 340 15.2.2.1 Nonobservability of Information 341 15.2.2.2 Asymmetric Information 341 15.3 Summary of Healthcare Applications 343 15.3.1 Incentive Design for Healthcare Providers 344 15.3.2 Quality-Speed Tradeoff 345 15.3.3 Gatekeepers 346 15.3.4 Healthcare Supply Chain 346 15.3.5 Vaccination 346 15.3.6 Organ Transplantation 347 15.3.7 Healthcare Network 347 15.3.8 Mixed Motives of Healthcare Providers 347 15.4 Potential Applications 348 15.4.1 Micro-Level applications 348 15.4.2 Macro-Level Applications 349 15.4.3 Meso-Level Applications 349 15.5 Resources for Learners 351 References 351 16 Queueing Games 355Mustafa Akan 16.1 Introduction 355 16.1.1 Scope of the Review 356 16.2 Basic QueueingModels 356 16.2.1 Components of a Queueing System 356 16.2.2 Performance Measures 357 16.2.3 M/M/1 358 16.2.4 M/G/1 359 16.2.5 M/M/c 360 16.2.6 Priorities 361 16.2.6.1 Achievable Region Approach 363 16.2.7 Networks of Queues 364 16.2.8 Approximations 364 16.3 Strategic Queueing 365 16.3.1 Waiting as an Equilibrium Device 366 16.3.2 Demand Dependent on Service Time 367 16.3.3 Physician-Induced Demand 369 16.3.4 Joining the Queue 370 16.3.4.1 Observable Queue 370 16.3.4.2 Unobservable Queue 371 16.3.5 Waiting for a Better Match 373 16.4 Discussion and Future Research Directions 376 References 376 17 EconometricMethods 381Diwas KC 17.1 Introduction 381 17.2 Statistical Modeling 382 17.2.1 Statistical Inference 383 17.2.2 Biased Estimates 384 17.3 The Experimental Ideal and the Search for Exogenous Variation 386 17.3.1 Instrumental Variables 386 17.3.1.1 Example 1 (IV): Patient Flow through an Intensive Care Unit 388 17.3.1.2 Example 2 (IV): Focused Factories 391 17.3.2 Difference Estimators 392 17.3.3 Fixed Effects Estimators 394 17.3.3.1 Examples 3-4 (D-in-D): Process Compliance and Peer Effects of Productivity 395 17.4 Structural Estimation 395 17.4.1 Example 5: Managing Operating Room Capacity 396 17.4.2 Example 6: Patient Choice Modeling 397 17.5 Conclusion 399 References 400 18 Data Science 403Rema Padman 18.1 Introduction 403 18.1.1 Background 404 18.1.2 Methods 407 18.1.3 Attribute Selection and Ranking 408 18.1.4 Information Gain (IG) Attribute Ranking 408 18.1.5 Relief-F Attribute Ranking 408 18.1.6 Markov Blanket Feature Selection 408 18.1.7 Correlation-Based Feature Selection 409 18.1.8 Classification 409 18.2 Three Illustrative Examples of Data Science in Healthcare 410 18.2.1 Medication Reconciliation 410 18.2.2 Dynamic Prediction of Medical Risks 413 18.2.3 Practice-Based Clinical Pathway Learning 416 18.3 Discussion 419 18.3.1 Challenges and Opportunities 419 18.3.2 Data Science in Action 420 18.3.3 Health Data ScienceWorldwide 421 18.4 Conclusions 421 References 422 Index 429

Read more less

Book Synopsis

Read more less

Book SynopsisHow can countries chart their own course toward universal health coverage?Like many ambitious global goals, universal health coverage (UHC) remains an aspiration for many countries. The World Health Organization estimates that half the world's population lacks access to basic health services. Moreover, this already staggering number masks inequities that exist between and within countries: gaps between rich and poor, men and women, young and old, and among people of different ethnic backgrounds. UHC promises to give all people greater access to higher quality health services without the fear of financial hardship. But the task of turning this vision into reality poses a significant challenge for countries at all stages of economic development. In The Road to Universal Health Coverage, Jeffrey L. Sturchio, Ilona Kickbusch, Louis Galambos, and their contributors explore the ways in which the private sector is already helping countries achieve universal health coverage. Stressing the maTable of ContentsForeword by Tedros Adhanom GhebreyesusPrefaceIntroduction. The Road to Universal Health Coverage: Progress, Prospects, and the Private SectorChapter 1. Conceptualizing the Health EconomyChapter 2. The Relationship between Health Employment and Economic GrowthChapter 3. Engagement of the Private Sector in Advancing Universal Health Coverage: Understanding and Navigating Major Factors for SuccessChapter 4. Innovative Initiatives from the Private Sector: What Have the Experiences Been? What Opportunities Lie Ahead, and How Can They Be Chapter 5. Healthy Women, Healthy Economies: Essential Facets of Universal Health Coverage Chapter 6. Reframing the Pharmaceutical Sector Contribution to Access to Medicines and Universal Health Coverage: A Business Ethics PerspectiveChapter 7. Private Sector Joins the Trek on India's Meandering Path to Universal Health CoverageChapter 8. A Reality Check: Sierra Leone, the Private Sector, Sustainable Development Goal 3, and Universal Health CoverageChapter 9. How Can the Private Sector Help Countries to Achieve Quality, Sustainable Universal Health Coverage? Pfizer's Fight against Chronic DiseasesChapter 10. Novartis Social Business: A Novel Approach to Expanding Health Care in Developing CountriesConclusion. The Outlook for Universal Health Coverage and the New Health Economy List of ContributorsIndex

Read more less

Book SynopsisThis second edition of this best-selling book offers a fresh look at how the British NHS is coping under increased pressures. It offers a critical perspective on concerns and a critique of the market-style changes introduced by the Coalition government between 2010 and 2015.Trade Review"This book is ideal for anyone with an interest in health policy, health systems development and the wider health agenda.... a useful resource for all students of health, health professionals, policy makers and strategy developers." Health Service Journal"Read this excellent book to find out where things have gone wrong in the NHS and why." 5 star review by a reader on Amazon.co.uk"A thoughtful assessment of recent NHS reforms that is more balanced and insightful than many of those produced by New Labour's critics. " Critical Social PolicyThis book's strength lies in the clarity of the argument and the presentation of evidence within a clear analytic framework." Sociology of Health & IllnessTable of ContentsSeries Editor’s preface; The Key Challenges Facing Health Systems; Meeting the Challenges; Moving Upstream: the dilemma of securing health in health policy; Models of Health Care Reform; Health Care Priorities; Choice and Health Care; Future Developments in the Evolution of Health Systems.

Read more less

Book SynopsisProviding an in-depth review of Russia's key economic policies, this book is the first systematic study of the political economy of oil windfalls in Putin's Russia.Table of ContentsAcknowledgments Introduction 1. Understanding Policy-Making in Resource-Rich Countries 2. The Upsurge in Executive Power under President Putin 3. Russia’s Historic Oil Windfalls and the Contest over Who Will Generate the Rents 4. Collecting the Rents: The Contest between the State and the Oil Industry on Dividing the Windfalls 5. The State as a Redistributor of Oil Rents: The Contest over Russia’s Budget and Economic Priorities 6. The State as a Redistributor of Oil Rents: The Battle to Save the Windfalls 7. The Oil Sector as a Redistributor of Rents Conclusion Notes Bibliography Index

Read more less

Book SynopsisThis edited collection explores how the value of training and skills invested in internationally educated health professionals is transferred, and transformed, and in some cases tarnished, at all stages of the international migration process.Table of ContentsIntroduction Global Migration, Gender and Health Professional Credentials: Transnational Value Transfers and Losses Margaret Walton-Roberts Section 1: Health Worker Migration and Global Value Transfer: New Approaches and Challenges 1. The Study of Global Value Chains: Bringing Services and People In John Ravenhill 2. Circulation of Love: Care Transactions in the Global Healthcare Market of Transnational Medical Travel Heidi Kaspar Section 2: Conceptualizing Workplace Integration and Stratification: Immigration Policy, International Credentials, and Intersectional Disadvantage 3. The Migration of Health Professionals to Canada: Reducing Brain Waste and Improving Labour Market Integration Arthur Sweetman 4. Global Migration and Key Issues in Workforce Integration of Skilled Health Workers Andrea Baumann, Mary Crea-Arsenio and V. Antonipillai 5. Gendering Integration Pathways: Migrating Health Professionals to Canada Ivy Bourgeault, Jelena Atanackovic and Elena Neiterman 6. The Global Intimate Workforce Caitlin Henry Section 3: Transnational Health Mobilities: Networks, Regulation and Intermediaries 7. Networking Through Kafala: Understanding Transnational Networks in the Governance of Skilled Migration in the Gulf Crystal Ennis 8. Migration Intermediaries and the Migration of Health Professionals from the Global South Abel Chikanda 9. Transnational Influence in the Philippines Nursing sector: Producing Hardworking, Subservient Nurses for the World Maddy Thompson Section 4: Domestic Policies in Receiving Countries: Value Transfer, Integration and Regulation 10. Transfer of Professional Qualifications of Foreign-Born Nurses: Gender, Migration, and Geographic Valuations of Skill Micheline Van Riemsdijk 11. Ten Years of Ontario’s Fair Access Law: Has Access to Regulated Professions Improved for Internationally Educated Individuals? Nuzhat Jafri 12. Migrant Care Workers in Australia – A Gathering Crisis? John Connell and Joel Negin 13. Care Worker Migration and Robotics in Japan's Aged Care Sector Hector Goldar Perrote and Margaret Walton-Roberts Section 5: Recasting Brain Drain and Global Circulation 14. Nursing the Nation: The intellectual Labor of Early Migrant Nurses in the U.S. and the Development of University Level Nursing Programs in the Philippines (1935-1965) Christine Peralta 15. From Brain Drain to Brain Retrain – A Case of Nigerian Nurses in Canada Sheri Adekola 16. Peripatetic Physicians: Rewriting the South African Brain Drain Narrative Jonathan Crush 17. Recasting the ‘Brain’ in ‘Brain Drain’: A Case Study From Medical Migration Parvati Raghuram, Joanna Bornat and Leroi Henry

Read more less

Book SynopsisThe new edition of this influential text addresses key issues about the past, present, and future of workers and unions in Canada.Table of ContentsList of Illustrations Preface to the Third Edition Preface to the Fourth Edition Foreword: Beyond Fatalism – Renewing Working-Class Politics by Sam Gindin Acronyms and Initialisms 1 From the Era of Consent to the Era of Coercion 2 The Postwar Era of Free Collective Bargaining 3 Permanent Exceptionalism: The Turn to Coercion 4 Freeing Trade, Coercing Labour 5 Consolidating Neoliberalism 6 Austerity and Authoritarianism 7 From Great Recession to COVID-19 Crisis 8 The Right to Strike: Freedom of Association and the Charter 9 Labour’s Last Gasp or Revival? Rebuilding Working-Class Resistance Notes Glossary Index

Read more less

Book SynopsisThe Multilevel Politics of Trade presents a timely comparative analysis of eight federations (plus the European Union) to explore why some sub-federal actors have become more active in trade politics in recent years. As the contributing authors find, there is considerable variation in the intensity and modes of sub-federal participation. This they attribute to three key factors: the distinctive institutional features of federal systems; the nature and scope of trade policy and trade agreements; and the extent of social mobilization that accompanies a particular trade policy conversation. As a whole, The Multilevel Politics of Trade argues that sub-federal actors’ interests (jurisdictional, political, and economic) are what motivate them to participate in trade debates. However, institutional configurations, coupled with the influence of civil society actors, political parties, and others determine the nature and scope of that participation. Informed by Table of Contents1. Introduction: The Evolution of Multilevel Trade Politics Jörg Broschek and Patricia Goff Section I. Canada in North America 2. Federalism and Trade Negotiations in Canada: CUSFTA, CETA, and TPP Compared Stéphane Paquin 3. Implementation of Twenty-First-Century Trade Agreements in Canada: CETA and Intergovernmental Cooperation Christian Hederer and Patrick Leblond 4. Reconceptualising Provincial Development: Evolving Public Procurement Practices in Quebec Sophie Schram 5. Multilevel Trade in the United States: Federalism, Internal Markets, and Intergovernmental Relations Michelle Egan 6. Mexican Sub-Federal Governments and the Negotiation and Implementation of Free-Trade Agreements Jorge A. Schiavon and Marcela López-Vallejo 7. Civil Society, Multilevel Governance, and International Trade in North America Christopher Kukucha Section II. Europe and Australia: Multilevel Trade Politics in Comparative Perspective 8. Federalism in Times of Increased Integration: The Participation of Cantons in Swiss Trade Policy Andreas R. Ziegler 9. Parallel Pathways? The Emergence of Multilevel Trade Politics in Austria and Germany Jörg Broschek, Peter Bußjäger, and Christoph Schramek 10. Trade Politics and the Australian States and Territories Annmarie Elijah 11. From Nada to Namur: National Parliaments’ Involvement in EU Trade Politics and the Case of Belgium Yelter Bollen, Ferdi De Ville, and Niels Gheyle Section III. The European Union: A Distinct Federation 12. Multilevel Politics of Trade in the European Union in the Aftermath of the Lisbon Treaty Maria Garcia 13. The Multilevel Politics of Trade: The Case of the Social Democrats in the European Parliament and the German SPD Myriam Gistelinck 14. Municipal Level Trade Contestation: Activists and Local Governments from the MAI to TTIP Gabriel Siles-Brügge and Michael Strange 15. Conclusion Jorg Broschek and Patricia Goff

Read more less

Book SynopsisNo sector has been as vital as oil to the Russian economy since Vladimir Putin came to power. The longest serving leader since Stalin, Putin has presided during a period of relative economic prosperity driven largely by booming oil windfalls. Oil in Putin’s Russia offers an in-depth examination of the contests over windfalls drawn from the oil sector. Examining how the Russian leadership has guided the process of distributing these windfalls, Adnan Vatansever explores the causes behind key policy continuities and policy reversals during Putin’s tenure. The product of over ten years of research, including interviews with decision-makers and oil industry officials, Oil in Putin’s Russia takes an innovative approach to understanding the contested nature of resource rents and the policy processes that determine how they are allocated. In so doing, it offers a comprehensive and timely account of politics and policy in contemporary Russia, and aTable of ContentsAcknowledgments Introduction 1. Understanding Policy-Making in Resource-Rich Countries 2. The Upsurge in Executive Power under President Putin 3. Russia’s Historic Oil Windfalls and the Contest over Who Will Generate the Rents 4. Collecting the Rents: The Contest between the State and the Oil Industry on Dividing the Windfalls 5. The State as a Redistributor of Oil Rents: The Contest over Russia’s Budget and Economic Priorities 6. The State as a Redistributor of Oil Rents: The Battle to Save the Windfalls 7. The Oil Sector as a Redistributor of Rents Conclusion Notes Bibliography Index

Read more less

Book SynopsisThis edited collection explores how the value of training and skills invested in internationally educated health professionals is transferred, and transformed, and in some cases tarnished, at all stages of the international migration process.Table of ContentsIntroduction Global Migration, Gender and Health Professional Credentials: Transnational Value Transfers and Losses Margaret Walton-Roberts Section 1: Health Worker Migration and Global Value Transfer: New Approaches and Challenges 1. The Study of Global Value Chains: Bringing Services and People In John Ravenhill 2. Circulation of Love: Care Transactions in the Global Healthcare Market of Transnational Medical Travel Heidi Kaspar Section 2: Conceptualizing Workplace Integration and Stratification: Immigration Policy, International Credentials, and Intersectional Disadvantage 3. The Migration of Health Professionals to Canada: Reducing Brain Waste and Improving Labour Market Integration Arthur Sweetman 4. Global Migration and Key Issues in Workforce Integration of Skilled Health Workers Andrea Baumann, Mary Crea-Arsenio and V. Antonipillai 5. Gendering Integration Pathways: Migrating Health Professionals to Canada Ivy Bourgeault, Jelena Atanackovic and Elena Neiterman 6. The Global Intimate Workforce Caitlin Henry Section 3: Transnational Health Mobilities: Networks, Regulation and Intermediaries 7. Networking Through Kafala: Understanding Transnational Networks in the Governance of Skilled Migration in the Gulf Crystal Ennis 8. Migration Intermediaries and the Migration of Health Professionals from the Global South Abel Chikanda 9. Transnational Influence in the Philippines Nursing sector: Producing Hardworking, Subservient Nurses for the World Maddy Thompson Section 4: Domestic Policies in Receiving Countries: Value Transfer, Integration and Regulation 10. Transfer of Professional Qualifications of Foreign-Born Nurses: Gender, Migration, and Geographic Valuations of Skill Micheline Van Riemsdijk 11. Ten Years of Ontario’s Fair Access Law: Has Access to Regulated Professions Improved for Internationally Educated Individuals? Nuzhat Jafri 12. Migrant Care Workers in Australia – A Gathering Crisis? John Connell and Joel Negin 13. Care Worker Migration and Robotics in Japan's Aged Care Sector Hector Goldar Perrote and Margaret Walton-Roberts Section 5: Recasting Brain Drain and Global Circulation 14. Nursing the Nation: The intellectual Labor of Early Migrant Nurses in the U.S. and the Development of University Level Nursing Programs in the Philippines (1935-1965) Christine Peralta 15. From Brain Drain to Brain Retrain – A Case of Nigerian Nurses in Canada Sheri Adekola 16. Peripatetic Physicians: Rewriting the South African Brain Drain Narrative Jonathan Crush 17. Recasting the ‘Brain’ in ‘Brain Drain’: A Case Study From Medical Migration Parvati Raghuram, Joanna Bornat and Leroi Henry

Read more less

Book SynopsisCreating Indigenous Property identifies how contemporary Indigenous conceptions of property are rooted in and informed by their societally specific norms, meanings, and ethics.Trade Review"Ultimately, with thorough examinations of Canadian legal instruments affecting Indigenous land and property rights, and lessons from the transnational context, Creating Indigenous Property examines ways to facilitate the debate on Indigenous land rights, promoting respect for Indigenous peoples diverse views and laws and exploring their compatibilization with Western legal mechanisms and systems. It is a very valuable collection for advocates of Indigenous land rights, policymakers, and scholars, in Canada and elsewhere." -- Ayla do Vale Alves * American Society of International Law *"I would strongly recommend this collection as an important vehicle for developing a better understanding of how the ‘capitalist-exploitation logic’ informs our relationships with Indigenous Peoples in this country." -- F. Tim Knight, Osgoode Hall Law School, York University * Canadian Law Library Review *Table of ContentsPreface Karen Drake Introduction: The Role of Indigenous Law in the Privatization of Lands Angela Cameron, Sari Graben, and Val Napoleon Part 1: Indigenous Law in Practice 1. Housing on Reserve: Developing a Critical Indigenous Feminist Property Theory Val Napoleon and Emily Snyder 2. Market Citizenship and Indigeneity Shalene Jobin 3. The Principle of Sharing and the Shadow of Canadian Property Law Sarah Morales and Brian Thom Part II: Political Issues 4. Property Rights on Reserves: "New" Ideas from the Nineteenth Century Sarah Carter and Nathalie Kermoal 5. Conceptualizing Aboriginal Taxpayers, Real Property, and Communities of Sharing Richard Daly 6. Indigenous Land Rights and the Politics of Property Jamie Baxter Part III: Common Law’s Response 7. The New Law-Making Powers of First Nations over Family Homes on Indian Reserves Michel Morin 8. Aboriginal Title in Tsilhqot’in: Exploring the Public Power of Private Property at the Supreme Court of Canada Sari Graben and Christian Morey Part IV: Lessons from the Transnational Context 9. Land, Niger Delta Peoples, and Oil and Gas Decision-Making Ibironke T. Odumosu-Ayanu 10. Locating the Woman: A Note on Customary Law and the Utility of Real Property in the Kingdom of Eswatini (Formerly the Kingdom of Swaziland) Tenille E. Brown Contributors

Read more less

Book SynopsisThe new edition of this influential text addresses key issues about the past, present, and future of workers and unions in Canada.Table of ContentsList of Illustrations Preface to the Third Edition Preface to the Fourth Edition Foreword: Beyond Fatalism – Renewing Working-Class Politics by Sam Gindin Acronyms and Initialisms 1 From the Era of Consent to the Era of Coercion 2 The Postwar Era of Free Collective Bargaining 3 Permanent Exceptionalism: The Turn to Coercion 4 Freeing Trade, Coercing Labour 5 Consolidating Neoliberalism 6 Austerity and Authoritarianism 7 From Great Recession to COVID-19 Crisis 8 The Right to Strike: Freedom of Association and the Charter 9 Labour’s Last Gasp or Revival? Rebuilding Working-Class Resistance Notes Glossary Index

Read more less

Book SynopsisThe Multilevel Politics of Trade presents a timely comparative analysis of eight federations (plus the European Union) to explore why some sub-federal actors have become more active in trade politics in recent years. As the contributing authors find, there is considerable variation in the intensity and modes of sub-federal participation. This they attribute to three key factors: the distinctive institutional features of federal systems; the nature and scope of trade policy and trade agreements; and the extent of social mobilization that accompanies a particular trade policy conversation. As a whole, The Multilevel Politics of Trade argues that sub-federal actors’ interests (jurisdictional, political, and economic) are what motivate them to participate in trade debates. However, institutional configurations, coupled with the influence of civil society actors, political parties, and others determine the nature and scope of that participation. Informed by Table of Contents1. Introduction: The Evolution of Multilevel Trade Politics Jörg Broschek and Patricia Goff Section I. Canada in North America 2. Federalism and Trade Negotiations in Canada: CUSFTA, CETA, and TPP Compared Stéphane Paquin 3. Implementation of Twenty-First-Century Trade Agreements in Canada: CETA and Intergovernmental Cooperation Christian Hederer and Patrick Leblond 4. Reconceptualising Provincial Development: Evolving Public Procurement Practices in Quebec Sophie Schram 5. Multilevel Trade in the United States: Federalism, Internal Markets, and Intergovernmental Relations Michelle Egan 6. Mexican Sub-Federal Governments and the Negotiation and Implementation of Free-Trade Agreements Jorge A. Schiavon and Marcela López-Vallejo 7. Civil Society, Multilevel Governance, and International Trade in North America Christopher Kukucha Section II. Europe and Australia: Multilevel Trade Politics in Comparative Perspective 8. Federalism in Times of Increased Integration: The Participation of Cantons in Swiss Trade Policy Andreas R. Ziegler 9. Parallel Pathways? The Emergence of Multilevel Trade Politics in Austria and Germany Jörg Broschek, Peter Bußjäger, and Christoph Schramek 10. Trade Politics and the Australian States and Territories Annmarie Elijah 11. From Nada to Namur: National Parliaments’ Involvement in EU Trade Politics and the Case of Belgium Yelter Bollen, Ferdi De Ville, and Niels Gheyle Section III. The European Union: A Distinct Federation 12. Multilevel Politics of Trade in the European Union in the Aftermath of the Lisbon Treaty Maria Garcia 13. The Multilevel Politics of Trade: The Case of the Social Democrats in the European Parliament and the German SPD Myriam Gistelinck 14. Municipal Level Trade Contestation: Activists and Local Governments from the MAI to TTIP Gabriel Siles-Brügge and Michael Strange 15. Conclusion Jorg Broschek and Patricia Goff

Read more less

Book SynopsisTransparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry to account through greater transparency.Table of Contents1. Introduction Katherine Fierlbeck, Janice Graham, and Matthew Herder 2. Transparency, Pharmaceuticals, and the Problem of Policy Change Katherine Fierlbeck 3. Data Transparency and Pharmaceutical Regulation in Europe: Road to Damascus, or Room without a View? Courtney Davis, Shai Mulinari, and Tom Jefferson 4. FDA and Health Canada: Similar Origins, yet Divergent Paths and Approaches to Transparency Margaret McCarthy and Joe Ross 5. Clinical Trial Data Transparency in Canada: Mapping the Progress from Laggard to Leader Marc-André Gagnon, Matthew Herder, Janice Graham, Katherine Fierlbeck, and Anna Danyliuk 6. How Clinical Study Information Transparency Can Fail to Serve Its Purpose, and How the Essential Medicines Concept Can Help Nav Persaud 7. Speak No Secrets: (Non)transparency in Health Canada’s Communications about Pharmaceutical Regulation Joel Lexchin 8. Economic Ghost-Management in the Pharmaceutical Sector Marc-Andre Gagnon 9. Balancing the Privacy Rights of Research Participants with the Public Interest in Clinical Drug Trials Data in the Context of Rare Diseases Kanksha Mahadevia Ghimire and Trudo Lemmens 10. The European Registration of the Pandemic Influenza Vaccine Pandemrix: A Case Study of the Consequences of Poor Clinical Data Transparency Tom Jefferson 11. Sharing Data and Ideas for Good Health: How Researchers Can Sustain an Ethical and Transparent Health System Rita Banzi 12. Conclusion Katherine Fierlbeck, Janice Graham, and Matthew Herder

Read more less

Book SynopsisTransparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry to account through greater transparency.Table of Contents1. Introduction Katherine Fierlbeck, Janice Graham, and Matthew Herder 2. Transparency, Pharmaceuticals, and the Problem of Policy Change Katherine Fierlbeck 3. Data Transparency and Pharmaceutical Regulation in Europe: Road to Damascus, or Room without a View? Courtney Davis, Shai Mulinari, and Tom Jefferson 4. FDA and Health Canada: Similar Origins, yet Divergent Paths and Approaches to Transparency Margaret McCarthy and Joe Ross 5. Clinical Trial Data Transparency in Canada: Mapping the Progress from Laggard to Leader Marc-André Gagnon, Matthew Herder, Janice Graham, Katherine Fierlbeck, and Anna Danyliuk 6. How Clinical Study Information Transparency Can Fail to Serve Its Purpose, and How the Essential Medicines Concept Can Help Nav Persaud 7. Speak No Secrets: (Non)transparency in Health Canada’s Communications about Pharmaceutical Regulation Joel Lexchin 8. Economic Ghost-Management in the Pharmaceutical Sector Marc-Andre Gagnon 9. Balancing the Privacy Rights of Research Participants with the Public Interest in Clinical Drug Trials Data in the Context of Rare Diseases Kanksha Mahadevia Ghimire and Trudo Lemmens 10. The European Registration of the Pandemic Influenza Vaccine Pandemrix: A Case Study of the Consequences of Poor Clinical Data Transparency Tom Jefferson 11. Sharing Data and Ideas for Good Health: How Researchers Can Sustain an Ethical and Transparent Health System Rita Banzi 12. Conclusion Katherine Fierlbeck, Janice Graham, and Matthew Herder

Read more less